UBS Group
OSCR icon

UBS Group’s Oscar Health OSCR Stock Holding History

UBS Group’s Portfolio OSCR Stock Details OSCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.15M Buy
+100,000
New +$1.41M ﹤0.01% 5449
2025
Q2 		– Sell
-40,000
Closed -$524K – 10676
2025
Q1 		$524K Buy
+40,000
New +$594K ﹤0.01% 5820

Other funds holding OSCR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
TCMNY
Thrive Capital Management (New York) New York $344M AUM 25.6% 1-Year Est. Return
BC
BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group's OSCR Position: Q1 2026 in Review

UBS Group increased its Oscar Health (OSCR) stake by 28% in Q1 2026, buying an estimated $4.8M and bringing the position to 1,574,978 shares worth $18.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2704.

UBS Group first reported a position in OSCR in Q2 2021 and has held it in 20 quarters since. The position peaked at $47.5M in Q3 2025. 330 funds tracked by Wall St. Rank hold OSCR as of Q1 2026.

  • UBS Group held 1,574,978 shares of Oscar Health worth $18.1M as of Q1 2026.
  • UBS Group bought 340,881 Oscar Health shares in Q1 2026, an estimated $4.8M.
  • Oscar Health made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #2704 holding.
  • UBS Group first reported a position in Oscar Health in Q2 2021 and has held it in 20 quarters since.
  • UBS Group's Oscar Health position peaked at $47.5M in Q3 2025.
  • 330 funds tracked by Wall St. Rank held Oscar Health as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.